Helio Genomics

Helio Genomics (formerly Helio Health) is an AI-driven healthcare company focused on developing and commercializing early cancer detection tests from a simple blood draw. Helio Genomics is a multinational business with collaborations in both the United States and China, including leading scientists, physicians, research institutions, and business leaders from both countries. Helio Genomics strives

to combine the experiences of these innovators and achievers in order to provide the healthiest and safest diagnostic technologies to everyone. Helio Genomics has CLIA and CAP certified laboratories, 3rd party laboratories, and cGMP facilities all working towards the endeavor of bringing these first-class technologies into the medical community.